Picture of Alkemy Capital Investments logo

ALK Alkemy Capital Investments News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

REG - Alkemy Capital Invs. - Notice of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240605:nRSE2783Ra&default-theme=true

RNS Number : 2783R  Alkemy Capital Investments PLC  05 June 2024

 

5 June 2024

 

Alkemy Capital Investments Plc

 

 

Notice of Annual General Meeting

 

Alkemy Capital Investments plc ("Alkemy") is pleased to announce that the
Annual General Meeting ("AGM") of the Company will be held at Simmons &
Simmons LLP, 1 Ropemaker Street, London EC2Y 9SS at 11.00 a.m. (BST) on 2 July
2023.

 

The Notice of AGM and Form of Proxy are now available for download from the
Company's website at www.alkemycapital.co.uk (http://www.alkemycapital.co.uk)
and are being posted to all shareholders this week.

 

Further information

For further information, please visit Alkemy's website:
www.alkemycapital.co.uk (about:blank) or TVL's website
www.teesvalleylithium.co.uk (about:blank) .

 

Further information

 

For further information, please visit Alkemy's
website: www.alkemycapital.co.uk (http://www.alkemycapital.co.uk/)  or TVL's
website www.teesvalleylithium.co.uk (http://www.teesvalleylithium.co.uk/) .

-Ends-

 Alkemy Capital Investments Plc  Tel: 0207 317 0636

                                 info@alkemycapital.co.uk (mailto:info@alkemycapital.co.uk)
 Zeus                            Tel: 020 3829 5000
 SI Capital Limited              Tel: 0148 341 3500

 

 

 

 

 

 

ABOUT ALKEMY CAPITAL

Alkemy is seeking to establish independent and sustainable lithium hydroxide
production by developing lithium sulphate and lithium hydroxide facilities in
the UK and Australia.

 

Alkemy, through its wholly owned UK subsidiary Tees Valley Lithium, has
secured a 9.6 ha brownfields site with full planning permission at the Wilton
International Chemicals Park in Teesside, a major UK Freeport, to build the
UK's first and one of Europe's largest lithium hydroxide processing facility.

 

Tees Valley Lithium has completed a Class 4 Feasibility Study for its proposed
lithium hydroxide refinery which will process feedstock imported from
various sources to produce 96,000 tonnes of premium, low-carbon lithium
hydroxide or an equivalent amount of lithium carbonate annually, representing
around 15% of Europe's projected demand.

 

Alkemy, through its wholly owned Australian subsidiary Port Hedland Lithium,
has secured a 43.7 ha site at the Boodarie strategic industry area, near Port
Hedland, Western Australia to build a world-class sustainable lithium sulphate
refinery that will provide reliable feedstock for Tees Valley Lithium's
refinery.

 

Port Hedland Lithium has completed a Class 4 Feasibility Study for its
proposed lithium sulphate refinery, each train of which will process spodumene
concentrate to produce 40,000 tonnes of lithium sulphate annually.

 

 

Forward Looking Statements

 

This news release contains forward‐looking information. The statements are
based on reasonable assumptions and expectations of management and Alkemy
provides no assurance that actual events will meet management's expectations.
In certain cases, forward‐looking information may be identified by such
terms as "anticipates", "believes", "could", "estimates", "expects", "may",
"shall", "will", or "would". Although Alkemy believes the expectations
expressed in such forward‐looking statements are based on reasonable
assumptions, such statements are not guarantees of future performance and
actual results or developments may differ materially from those projected. In
addition, factors that could cause actual events to differ materially from the
forward-looking information stated herein include changes in market
conditions, changes in metal prices, general economic and political
conditions, environmental risks, and community and non-governmental actions.
Such factors will also affect whether Alkemy will ultimately receive the
benefits anticipated pursuant to relevant agreements. This list is not
exhaustive of the factors that may affect any of the forward‐looking
statements. These and other factors should be considered carefully and readers
should not place undue reliance on forward-looking information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOASSFFLIELSEEM

Recent news on Alkemy Capital Investments

See all news